Massive Bio Announces Collaboration with Hematology Oncology Associates of Palm Beach
July 7, 2017
Hematology Oncology Associates of Palm Beach and Massive Bio, Inc. announced today that they are beginning their collaboration to deliver expert medical second opinions and cutting-edge precision oncology advisory services to cancer patients in Southern Florida.
Hematology Oncology Associates of Palm Beaches and its 35 years of experience with Massive Bio’s team of Oncology experts will allow patients to remain in their local Oncologists care while utilizing Massive Bio’s healthcare informatics, oncology experts and molecular diagnostic scientists from top academic cancer centers to provide treatment.
“By combining Massive Bio’s next dimension of cancer care with Hematology Oncology Associates of Palm Beach’s unique expertise and reach in Florida, we will be able to improve the outcome for patients who have exhausted standard of care options,” said Dr. William L. Sternheim, President of Hematology Oncology Associates of Palm Beach.
The strategic collaboration will allow patients already benefitting from the Hematology Oncology Associates of Palm Beach’s platform and services to seamlessly access the Massive Bio platform. Hematology Oncology Associates of Palm Beach will work closely with the team at Massive Bio to provide the most comprehensive care to their patients.
“We are excited about leveraging the power of Hematology Oncology Associates of Palm Beach’s footprint in Florida to support more cancer patients. We translate state-of-the-art precision oncology expertise to patients and the overall cancer community, which may improve patient outcomes across the US and beyond, while minimizing the high cost of cancer care, improving access to clinical trials and gaining precious time for patients,” said Selin Kurnaz, Massive Bio’s Co-founder and CEO.